Celeris Therapeutics
The PIC Engineering Company.
1 employees · est. 2021 · Menlo Park, United States
Celeris Therapeutics is the older company (2021 vs 2022); Profluent is the larger of the two.
Side-by-Side Comparison
| Metric | Celeris Therapeutics | Profluent |
|---|---|---|
| Founded | ||
| Founded | 2021 older | 2022 |
| Headquarters | ||
| Headquarters | Menlo Park, United States | Emeryville, United States |
| Employees | ||
| Employees | 1 | 69 larger |
| Industry | ||
| Industry | AI, Biotechnology, Information Technology | AI, Biotechnology |
| Funding Stage | ||
| Funding Stage | Series Unknown | Series Unknown |
| Total Funding | ||
| Total Funding | $16.50M | $44.00M |
| Funding Rounds | ||
| Funding Rounds | 5 | 2 |
| Services | ||
| Services | Not tracked yet | AI-authored Protein Solutions, CRISPR Gene Editing, Custom Protein Design, Biological Research and Development |
| Target Customers | ||
| Target Customers | Not tracked yet | Pharmaceutical Companies, Agricultural Biotechnology Firms, Industrial Biotech Manufacturers, Research Institutions |
| Taxonomy | ||
| Taxonomy | AI-driven Drug Discovery, Proximity-inducing Compounds, Targeted Protein Degradation, CNS Therapeutics, Oncology Therapeutics, Drug Design Automation, Collaborative Drug Development, Geometric Deep Learning, Small-molecule Degraders, Biotech Collaboration, Molecular Glue, Machine Learning-driven Prediction, Protein-protein Interaction, Drug Pipeline, Automated Laboratory Devices | AI-first Protein Design, Deep Generative Models, Novel Proteins, Biomedicine Revolution, Functional Protein Design, Protein Validation, AI In Biotech, Gene Editing, Machine Learning Applications, Biotech Innovation, Synthetic Biology, Life Sciences, Therapeutic Protein Development, Biomedical Research, Computational Biology |
| Website | ||
| Website | celeristx.com | profluent.bio |
About Celeris Therapeutics
Celeris Therapeutics, founded in 2021, is at the forefront of revolutionizing drug discovery using artificial intelligence. Its proprietary platform, CelerisTx One™, leverages deep learning for the innovative design of PROTACs (proximity-inducing compounds). By focusing on the development of New Che...
About Profluent
Profluent, a pioneering player in the intersection of AI and biotechnology, is making significant strides in revolutionizing protein design. Established in 2022, the company is based in Emeryville, CA, and has garnered support from top-tier investors including Spark Capital, Insight Partners, Air St...
We will tell you when either one moves
BounceWatch watches Celeris Therapeutics and Profluent for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Celeris Therapeutics and Profluent — by email.
Frequently Asked Questions
Compare Celeris Therapeutics with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Celeris Therapeutics on 29 May 2025, and Profluent on 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.